Systematic investigation of the relationships between 25 crystal structures containing the carbamazepine molecule or a close analogue: a case study of the XPac method
暂无分享,去创建一个
[1] L. Fábián,et al. Dipole-induced polymorphs of trans-2-hydroxycycloheptanecarboxylic acid with virtually the same unit cell. , 2003, Journal of the American Chemical Society.
[2] J. McMahon,et al. Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.
[3] A. P. Lötter,et al. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. , 1987, Journal of pharmaceutical sciences.
[4] G. Reck,et al. Kristallstrukturen der Addukte Carbamazepin-Ammoniumchlorid und Carbamazepin-Ammoniumbromid sowie deren umwandlung in Carbamazepin-Dihydrat , 1991 .
[5] G. Reck,et al. The Order‐Disorder Structure of Carbamazepine Dihydrate: 5 H‐Dibenz [b, f] azepine‐5‐carboxamide Dihydrate, C15H12N2O · 2 H2O , 1986 .
[6] A. Matzger,et al. Form IV of carbamazepine. , 2002, Journal of pharmaceutical sciences.
[7] Alan R. Kennedy,et al. Polymorphism in 2-4-6 trinitrotoluene , 2003 .
[8] P. York,et al. Characterization of dihydrates prepared from carbamazepine polymorphs. , 1996, Journal of pharmaceutical sciences.
[9] C. Gervais,et al. Simple model designed to generate new crystal structures derived from a mother phase; application to molecular compounds. , 2002, Acta crystallographica. Section B, Structural science.
[10] Michael B. Hursthouse,et al. A versatile procedure for the identification, description and quantification of structural similarity in molecular crystals , 2005 .
[11] F. Krahn,et al. Relations between several polymorphic forms and the dihydrate of carbamazepine. , 1987, Pharmaceutica acta Helvetiae.
[12] A. Dzyabchenko,et al. X-ray characterization of the triclinic polymorph of carbamazepine. , 1997, Journal of pharmaceutical sciences.
[13] J. Guyot,et al. Polymorphic Transitions of Carbamazepine During Grinding and Compression , 1986 .
[14] A. Matzger,et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.
[15] N. Kaneniwa,et al. [Hygroscopicity of carbamazepine crystalline powders]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[16] J. Rouland,et al. Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate. , 1991, Pharmaceutica acta Helvetiae.
[17] D. Brooke,et al. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. , 1991, Journal of pharmaceutical sciences.
[18] C. Rustichelli,et al. Solid-state study of polymorphic drugs: carbamazepine. , 2000, Journal of pharmaceutical and biomedical analysis.
[19] A. Gavezzotti,et al. Molecular recognition in organic crystals: directed intermolecular bonds or nonlocalized bonding? , 2005, Angewandte Chemie.
[20] V. Nesterov,et al. Systematic study of polymorphism in crystalline non-linear optical materials , 2003 .
[21] R. S. Payne,et al. Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] F. Allen. The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.
[23] V. L. Himes,et al. Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide , 1981 .
[24] K. Kuroda,et al. [Kinetics of the thermal transition of carbamazepine polymorphic forms in the solid state]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[25] Carbamazepine N,N-dimethylformamide solvate , 2005 .
[26] László Fábián,et al. Isostructurality in one and two dimensions: isostructurality of polymorphs. , 2004, Acta crystallographica. Section B, Structural science.
[27] Carbamazepine furfural hemisolvate , 2005 .
[28] Gautam R. Desiraju,et al. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .
[29] G. Bandoli,et al. X-ray crystallographic characterization of 10,11-dihydro-5H-dibenz[b, f ]azepine-5-carboxamide , 1992 .
[30] Peddy Vishweshwar,et al. The predictably elusive form II of aspirin. , 2005, Journal of the American Chemical Society.
[31] Raymond E. Davis,et al. Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .
[32] S. Itai,et al. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. , 2000, International journal of pharmaceutics.
[33] J. Saldanha,et al. Crystal and molecular structure of 5-carbamyl-5H-dibenzo[b,f] azepine , 1989 .
[34] J. Reboul,et al. 5H‐Dibenz[b,f]azépinecarboxamide‐5 (carbamazépine) , 1981 .